Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

NCT05363800 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

Interventions

DRUG: HRS-3738

Sponsor

Jiangsu HengRui Medicine Co., Ltd.